ChemicalBook

7'-Methyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]iMidazole

 структура
884330-09-0
CAS №
884330-09-0
английское имя:
7'-Methyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]iMidazole
Синонимы:
Telmisartan Impurity 22;Telmisartan impurities1037;Dibenzimidazole N-Desmethyl;Telmisartan Diphenyl Demethyl Impurity;Telmisartan Desmethyl Dibenzimidazole Im;4'-Methyl-2'-propyl-2,6'-bi-1H-benziMidazole;7'-Methyl-2'-propyl-2,5'-bi-1H-benziMidazole;TelMisartan-DesMethyl DibenziMidazole IMpurity;2,5'-Bi-1H-benzimidazole, 7'-methyl-2'-propyl-;TelMisartan DiBenziMidazole N-DesMethyl IMpurity
CBNumber:
CB32552595
Формула:
C18H18N4
молекулярный вес:
290.36
MOL File:
884330-09-0.mol

7'-Methyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]iMidazole атрибут

Температура кипения: 603.7±57.0 °C(Predicted)
плотность: 1.253±0.06 g/cm3(Predicted)
пка: 11.33±0.10(Predicted)

Заявления о рисках и безопасности

7'-Methyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]iMidazole химические свойства, назначение, производство

Использование

An impurity of Telmisartan (D294250).

7'-Methyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]iMidazole препаратная продукция и сырье

сырьё

препарат


7'-Methyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]iMidazole поставщик

Global( 35)Suppliers
поставщик телефон страна номенклатура продукции благоприятные условия
China National Standard Pharmaceutical Corporation Limited
+8615391658522
China 11927 58
sgtlifesciences pvt ltd
+8617013299288
China 12382 58
CR Corporation Limited
+8613062833949
China 8647 58
Career Henan Chemica Co
+86-0371-86658258 +8613203830695
China 30250 58
Shanghai Haohong Scientific Co., Ltd. 400-400-8210725
China 39953 58
Nantong Hanfang Biotechnology Co. , Ltd. 18616537568
China 30968 58
Shanghai YuZn Pharm. Technology Co.,Ltd. 15921286451; 15921286451
China 5079 58
Shanghai Kewel Chemical Co., Ltd. 021-64609169 18901607656
China 9911 50
Hubei De'ao Chemical Research Pharmaceutical Technology Co., Ltd 18502726233; 18502726233
China 9809 58
Hubei Ruinuo Pharmaceutical Technology Co., Ltd 13165688766
China 5000 58
Copyright 2017 © ChemicalBook. All rights reserved